- 関
- artemether-lumefantrine
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- Assessment of therapeutic efficacy and safety of artemether-lumefantrine (Coartem®) in the treatment of uncomplicated Plasmodium falciparum malaria patients in Bahir Dar district, Northwest Ethiopia: an observational cohort study.
- Ebstie YA1, Zeynudin A2, Belachew T3, Desalegn Z4, Suleman S5.
- Malaria journal.Malar J.2015 Jun 5;14:236. doi: 10.1186/s12936-015-0744-x.
- BACKGROUND: Malaria is a complex disease, which varies in its epidemiology and clinical manifestation. Although artemether-lumefantrine has been used as first-line drug for uncomplicated Plasmodium falciparum malaria in Bahir Dar district since 2004, its efficacy has not yet been assessed. The main
- PMID 26045199
- Integration of novel low-cost colorimetric, laser photometric, and visual fluorescent techniques for rapid identification of falsified medicines in resource-poor areas: application to artemether-lumefantrine.
- Green MD1, Hostetler DM2, Nettey H2, Swamidoss I2, Ranieri N2, Newton PN2.
- The American journal of tropical medicine and hygiene.Am J Trop Med Hyg.2015 Jun;92(6 Suppl):8-16. doi: 10.4269/ajtmh.14-0832. Epub 2015 Apr 20.
- The availability of falsified antimalarial drugs can be reduced with effective drug regulatory agencies and proper enforcement. Fundamental to these agencies taking action, rapid identification must be made as soon as they appear in the market place. Since falsified antimalarials occur mostly in dev
- PMID 25897066
- The effect of dose on the antimalarial efficacy of artemether-lumefantrine: a systematic review and pooled analysis of individual patient data.
- Worldwide Antimalarial Resistance Network (WWARN) AL Dose Impact Study Group.
- The Lancet. Infectious diseases.Lancet Infect Dis.2015 Jun;15(6):692-702. doi: 10.1016/S1473-3099(15)70024-1. Epub 2015 Mar 16.
- BACKGROUND: Artemether-lumefantrine is the most widely used artemisinin-based combination therapy for malaria, although treatment failures occur in some regions. We investigated the effect of dosing strategy on efficacy in a pooled analysis from trials done in a wide range of malaria-endemic setting
- PMID 25788162
Japanese Journal
- 抗マラリア薬研究の進歩 : 青高素(チンハオス)とその誘導体の単独および他剤との併用療法
- 海老沢 功
- 日本化学療法学会雜誌 = Japanese journal of chemotherapy 55(5), 351-357, 2007-09-10
- NAID 10019864124
Related Links
- プレスリリース 2008年9月19日 報道関係各位 ノバルティス ファーマ株式会社 ノバルティス(スイス)が発表しましたリリースの日本語訳(要約)をお届けします。マラリア治療薬Coartem ® 、米FDAが優先審査品目に指定 Coartem ® は ...
- Use of this website is governed by our Terms of Use and Privacy Policy © Novartis Pharma AG 2014 03/14 NP4 169038
Related Pictures